James G. Bender1
Xuemo Fan1
John S. Yu1
1James G. Bender
1Xuemo Fan
1John S. Yu
Learn More
BACKGROUND This study evaluated the safety and immune responses to an autologous dendritic cell vaccine pulsed with class I peptides from tumor-associated antigens (TAA) expressed on gliomas and overexpressed in their cancer stem cell population (ICT-107). METHODS TAA epitopes included HER2, TRP-2, gp100, MAGE-1, IL13Rα2, and AIM-2. HLA-A1- and/or(More)
  • 1